Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

18.70 +0.20 (+1.08%)

Streaming Delayed Price Updated: 12:38 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence

January 05, 2026

The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The...

Via MarketMinute

Topics Earnings

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

December 20, 2025

The famous investor's funds were active buyers in the run-up to the holidays.

Via The Motley Fool

Topics Bonds ETFs

Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture

December 01, 2025

Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across...

Via TokenRing AI

Topics Artificial Intelligence Economy Emissions

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

What 4 Analyst Ratings Have To Say About Schrodinger ↗

August 18, 2025

Via Benzinga

Moss Spores Defy the Void: A Tiny Plant’s Giant Leap for Astrobiology and Off-World Ecosystems

November 24, 2025

Recent groundbreaking research has revealed the astonishing resilience of moss spores, with over 80% surviving a nine-month exposure to the brutal conditions on the exterior of the International Space...

Via TokenRing AI

Topics Artificial Intelligence

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as...

Via TokenRing AI

Topics Artificial Intelligence Climate Change Intellectual Property

Schrodinger Downgraded By Citi After Ending Blood Cancer Drug Trial Tied To 2 Deaths; Retail Voices Concern ↗

August 15, 2025

Via Stocktwits

Schrödinger Discontinues Clinical Program After Two Patient Deaths ↗

August 14, 2025

Via Stocktwits

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Earnings Scheduled For February 26, 2025 ↗

February 26, 2025

Via Benzinga

AI Unlocks Cosmic Secrets: Revolutionizing Discovery in Physics and Cosmology

November 05, 2025

Artificial Intelligence (AI) is ushering in an unprecedented era of scientific discovery, fundamentally transforming how researchers in fields like cosmology and physics unravel the universe's most...

Via TokenRing AI

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

November 03, 2025

Via Benzinga

Expert Outlook: Schrodinger Through The Eyes Of 5 Analysts ↗

September 30, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors

October 04, 2025

As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for...

Via MarketMinute

Topics Artificial Intelligence Climate Change Economy

Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape

September 19, 2025

Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery...

Via MarketMinute

Topics Animal Testing Artificial Intelligence Intellectual Property

Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn

August 27, 2025

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

August 15, 2025

Via Benzinga

This AZZ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

August 14, 2025

Via Benzinga

Schrödinger (SDGR) Q2 2025 Earnings Transcript ↗

August 06, 2025

Via The Motley Fool

3 Momentum Stocks That Could Soar Post-Market Volatility

April 21, 2025

Three unexpected companies have rallied quickly in the period following tariff-related market turbulence; can they maintain momentum?

Via MarketBeat

Topics Artificial Intelligence World Trade

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗

April 14, 2025

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Via Benzinga

Topics Animal Testing

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗

April 11, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

April 10, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements ↗

April 10, 2025

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing...

Via Benzinga

Topics Animal Testing

AI Pharma: 2 Paths to AI-Powered Drug Investment

January 28, 2025

AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.

Via MarketBeat

Topics Artificial Intelligence

Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗

January 22, 2025

Via Benzinga

Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details ↗

November 12, 2024

Schrödinger shares rise as they announce a research partnership and licensing agreement with Novartis AG. Schrödinger will receive $150 million upfront and eligible to receive up to approximately $2.3...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Schrodinger, Inc. - Common Stock (NQ:SDGR)

Headline News about Schrodinger, Inc. - Common Stock